Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-05 16:59 |
Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and P…
|
English | 479.3 KB | ||
| 2024-11-05 16:59 |
Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and P…
|
English | 36.4 KB | ||
| 2024-10-29 13:59 |
to Release Third Quarter 2024 Financial Results and conference call on
Tuesday,…
|
English | 91.9 KB | ||
| 2024-10-29 13:59 |
to Release Third Quarter 2024 Financial Results and conference call on
Tuesday,…
|
English | 36.4 KB | ||
| 2024-10-07 15:59 |
To Present New Clinical Data at SITC 2024
|
English | 91.0 KB | ||
| 2024-10-07 15:59 |
To Present New Clinical Data at SITC 2024
|
English | 36.3 KB | ||
| 2024-09-13 15:59 |
Results of an Annual Meeting of Shareholders held on September 12, 2024
|
English | 52.1 KB | ||
| 2024-09-13 15:59 |
Results of an Annual Meeting of Shareholders held on September 12, 2024
|
English | 36.2 KB | ||
| 2024-09-09 15:59 |
to Present at Single Cell Genomics 2024 Conference
|
English | 85.4 KB | ||
| 2024-09-09 15:59 |
to Present at Single Cell Genomics 2024 Conference
|
English | 36.3 KB | ||
| 2024-08-29 15:59 |
Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Confer…
|
English | 84.0 KB | ||
| 2024-08-29 15:59 |
Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Confer…
|
English | 36.3 KB | ||
| 2024-08-27 16:26 |
Immediate Report about change of identifying details
|
English | 39.7 KB | ||
| 2024-08-06 15:59 |
Second Quarter 2024 Results
|
English | 234.2 KB | ||
| 2024-08-06 15:59 |
Second Quarter 2024 Results
|
English | 36.2 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
